Educational content on VJNeurology is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

Share this video  

IHC 2021 | Upcoming research in migraine treatment and prevention

Gisela Terwindt, MD, PhD, Leiden University, Leiden, Netherlands, expresses her excitement on new data and ongoing studies showing which patients will benefit the most from CGRP inhibitors. Prof. Terwindt is hopeful that we will be able to develop new preventative migraine treatment strategies for patients. The importance of studying genomics, metabolomics, and proteomics in other neurological diseases is also highlighted to achieve a better understanding of the -omics field in migraine. This interview took place during the International Headache Congress 2021.

Disclosures

Leadership or Board position in other society, committee or advocacy group: Board member of Dutch Headache Society, Advisory member of Dutch Headache Alliance.
Membership of any professional bodies, special interest groups or mutual support organizations: Dutch Neurologist Society, Dutch Headache Society, European Headache Society.
Consultancy: Novartis, Teva, Allergan, Lilly, Lundbeck.
Research support paid to institutions: Dutch Brain Foundation, Dutch Hearth Foundation, Dutch Research Council, IRRF, Dioraphte.
Royalties or licenses: Up to date (RVCL-S), Dutch Neurology Handbook.
Patents planned, issued or pending: E-diary (patient journey) collaboration with Interactive Studios (Dutch Company).
Participation on a Data Safety Monitoring Board or Advisory Board: CGRP Education and Research Forum.
Clinical trials involvement: WHATstudy (independent study with support of the Dutch Brain Foundation and the Dutch research council) on the effect of hormonal treatment in migraine, National PI in the Alleviate and Chronicle studies by Lundbeck on episodic and chronic CH.
Relationship with scientific journals: Regular reviewer for Cephalalgia, J Headache Pain, Headache, Neurology, Lancet (Neurology), Brain.
Commercial interest in companies, partnerships and other forms of business: E-dairy Patient Journey with Interactive Studios.
Gifts received from companies, partnerships and other forms of business: Presenter for satellite symposia/webinars with Springer Media (Mednet)/Ashfield MedComms.